Suggestions
Attila Borbáth
Co-Founder, CEO @ Synergia Medical SA | Innovating Medical Technology
Attila Borbáth is an experienced entrepreneur and business executive currently serving as the Co-Founder and CEO of Synergia Medical SA, a medical technology startup based in Louvain-la-Neuve, Belgium.1 The company focuses on developing neurostimulator devices.1
Professional Background
Borbáth has a diverse professional background spanning multiple industries:
-
Medical Technology: As the Co-Founder and CEO of Synergia Medical SA since September 2013, he leads the development of innovative medical devices.1
-
Sports Technology: He co-founded and served as VP of Sales and Marketing at Guru Motion Systems SA from 2010 to 2013, a startup specializing in 3D analysis software for sports movements.1
-
Financial Technology: Borbáth worked as a Senior Business Development Executive at Odyssey Financial Technologies for over 11 years, focusing on portfolio management software.1
-
Aviation: He held a position as an Airline Pilot with the Belgian Civil Aviation Authority from 2000 to 2003.1
-
Manufacturing: Borbáth served as Deputy Director at ETEX Group from 1996 to 1999.1
Education
Attila Borbáth has a strong educational background:
- Master of Science in Business and Engineering from Université catholique de Louvain1
- CEMS Master in International Management from ESADE Business School1
- Airline Transport Pilot License from Belgian Aeronautics1
Skills and Attributes
Borbáth is described as well-travelled, multilingual, and energetic, with remarkable management, entrepreneurial, marketing, and business development skills.2 His LinkedIn profile indicates proficiency in French, Dutch, Hungarian, Spanish, and English.1
Through his diverse experiences and educational background, Attila Borbáth has developed a unique skill set that combines technical knowledge, business acumen, and leadership abilities, which he now applies in his role at Synergia Medical SA.
Highlights
A week ago, we were excited at Synergia to publish a paper in the Nature Portfolio, highlighting our new optoelectronic neuromodulation technology: https://lnkd.in/eueVPGku.
I now take this opportunity to thank all our internal collaborators and worldwide subcontractors who have played a crucial role in developing this innovation. I look forward to the next step: our First in Human study in Belgium, led by Prof. Dr. Kristl Vonck Kristl Vonck and Prof. Dr. Riëm El Tahry Riem El Tahry.
Special thanks to Herbert Rooijakkers and Frank Dewaele, the neurosurgeons who will perform the first patient implantation of this transformative device and who have been crucial in its development over the years.
This reminds us of our responsibility to keep innovating, challenge the status quo, work towards a healthier future, and never lose sight of the human element at the heart of our work.
The presentation by Synergia Medical at #LSIEurope23 received a great response! Connecting with fellow entrepreneurs and the investor community here in Barcelona was wonderful. Thank you, and see you next year!
